Guidance on vaccination of HIV-infected children in Europe. - Wikidata - wikimedia - TriplyDB

Guidance on vaccination of HIV-infected children in Europe.

Guidance on vaccination of HIV-infected children in Europe.

http://www.wikidata.org/entity/Q34251138

about

Immunization of children with secondary immunodeficiency Pneumococcal Vaccination in High-Risk Individuals: Are We Doing It Right?Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection.Immunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.Undervaccination of perinatally HIV-infected and HIV-exposed uninfected children in Latin America and the Caribbean.Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations.Immunization of HIV-infected adult patients - French recommendations.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.Premature ageing of the immune system relates to increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1-infected and kidney-transplanted patients.Immunity Following Childhood Vaccinations in Perinatally HIV-Exposed Children with and without HIV Infection in Latin America.

P2860

Q26801474-4F2CDA34-DAAB-4E47-8667-9C7A0CDE5A26 Q28070059-DBEA4C7D-3683-4EF5-A8D8-DFD28FB5E636 Q34196888-BA469405-3F7D-4EAB-8729-C0AAA713E3DC Q35680467-5AE9D091-52AE-4420-A686-20D2991A6643 Q35887330-C45A4749-B197-45A3-B8E6-6FE8D9EAC064 Q37029106-5BEA2A25-9735-423C-A9A2-4296CA9D4DBF Q38036063-190AFE6C-A3F5-446D-B038-9792EB20E8D9 Q38198120-7538F1C4-5175-4027-9826-C5BF38E0103E Q40615516-72AD0324-3993-48FE-8DE2-A47D0818F27D Q41505058-28250D82-37F9-4A45-9658-A52FA0DB5BF1 Q41927775-CA858ADF-75E4-4E8B-BE48-63203722894A Q42255696-46CAB41A-0068-42F0-AA3F-9D0AB0351C44 Q47579533-36DEF17A-6F42-4354-BBE3-F27999D48005

P2860

Guidance on vaccination of HIV-infected children in Europe.

http://www.wikidata.org/entity/Q34251138

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Guidance on vaccination of HIV-infected children in Europe.

@ast

Guidance on vaccination of HIV-infected children in Europe.

@en

Guidance on vaccination of HIV-infected children in Europe.

@nl

type

label

Guidance on vaccination of HIV-infected children in Europe.

@ast

Guidance on vaccination of HIV-infected children in Europe.

@en

Guidance on vaccination of HIV-infected children in Europe.

@nl

prefLabel

Guidance on vaccination of HIV-infected children in Europe.

@ast

Guidance on vaccination of HIV-infected children in Europe.

@en

Guidance on vaccination of HIV-infected children in Europe.

@nl

P1433

Q34251138-97B8E0F9-01E4-4A71-B2DE-54DC6BA94AAD

P1476

Q34251138-372FBEA9-37AB-4A0F-8A0C-F957718821B4

P2093

Q34251138-09612E30-5EEA-4FD7-A04A-12C73D9F1926

Q34251138-0DF951F2-908D-4C0C-8C69-944A4E0E8F09

Q34251138-4021F590-855C-492D-970F-32C48D391EDA

Q34251138-4B8EA03E-F7C5-4F5C-9467-3E6B1869A9D0

Q34251138-891FDCED-E416-4597-94D2-EFA862802077

Q34251138-9490263B-AE9E-41C7-9581-AF2837F7C326

Q34251138-98876778-0355-43F4-966F-49E10D7E2F98

Q34251138-A406062B-BAC1-429B-A3DD-3223D2CE5784

Q34251138-D39879C9-1D6C-4443-BA45-C7E176FCA85B

Q34251138-F9F1E750-6A47-4EBA-B0B4-67F72B0E3CBC

P2860

Q34251138-02763FEF-631D-440C-9421-F889C36FEED0

Q34251138-0287EFFF-A6A0-40CD-8DF4-BE98A215EC29

Q34251138-0EB65925-398D-4253-963C-6516378A0E51

Q34251138-0F58C811-34E2-4F22-9F0D-A68B9E1BE8F5

Q34251138-1A1D2495-1E25-49AF-8A29-458B71C298A9

Q34251138-1A3D192B-8188-4762-A772-D22B46FAC968

Q34251138-1AED63C6-D502-4F00-BE24-D5EE9C8FCC50

Q34251138-1CAE1BD9-34E8-4885-A715-E8A7189CF003

Q34251138-1E948097-F348-40E1-8EA3-62F96936CC02

Q34251138-219B5B39-1A03-4E65-966B-145C3A272027

P304

Q34251138-422BA472-413F-4393-AA5E-190D8561FBA1

P31

Q34251138-112EC9B8-AB36-4131-A870-84926283E259

P356

Q34251138-A275D79B-594C-4430-8541-858F65789CC2

P433

Q34251138-3694A825-F0B1-4867-85E6-15103FF0C9A6

P478

Q34251138-9D43DC5B-EFA1-415C-BB39-ABC221FA1E19

P50

Q34251138-5F376632-3C6B-4FE4-81E8-BB353EFA4D01

Q34251138-7C347AF8-4DA9-4A22-AF82-2E56BC79A000

P577

Q34251138-F3389431-4FA6-4486-A155-002F29F20DE9

P698

Q34251138-14D85899-3659-4DB5-9B61-BFFA8AF0377C

P356

J.1468-1293.2011.00982.X

P1433

P1476

Guidance on vaccination of HIV-infected children in Europe

@en

P2093

A Bamford

http://www.w3.org/2001/XMLSchema#string

Children's HIV Association (CHIVA)

http://www.w3.org/2001/XMLSchema#string

D Duiculescu

http://www.w3.org/2001/XMLSchema#string

E N Menson

http://www.w3.org/2001/XMLSchema#string

H J Scherpbier

http://www.w3.org/2001/XMLSchema#string

M L Navarro

http://www.w3.org/2001/XMLSchema#string

M J Mellado

http://www.w3.org/2001/XMLSchema#string

P T Heath

http://www.w3.org/2001/XMLSchema#string

PENTA Steering Committee

http://www.w3.org/2001/XMLSchema#string

Paediatric European Network for Treatment of AIDS (PENTA) Vaccines Group

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.

HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

Effectiveness of varicella vaccine in children infected with HIV

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.

P304

333-6; e1-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1293.2011.00982.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Guido Castelli-Gattinara

Magdalena Marczyńska

P577

2012-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22296225

http://www.w3.org/2001/XMLSchema#string